Compared to Nb-BiTE- and PBS-treated mice, Nb-TriTE-treated mice had an increased number of human CD3+ CD8+ T cells in the tumor and spleen after treatment (Fig. 6 H, J, K). Here, CD8A is linked to neoplasm.